ROBERTA RAKOWSKI: Open Payments
NPI 1831366293 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 13 payments from 7 companies in 2025. Trend: 2023 $225 · 2024 $384 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $85 |
| ABBVIE INC. | 3 | $46 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: VRAYLAR, JARDIANCE, MOUNJARO, GEMTESA, XIFAXAN, ZEPBOUND, GVOKE HYPOPEN, FARXIGA.
Industry payments across TN — which companies pay providers there.
